These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29420337)
1. Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species. Qing X; Shao Z; Lv X; Pu F; Gao F; Liu L; Shi D Anticancer Drugs; 2018 Apr; 29(4):341-352. PubMed ID: 29420337 [TBL] [Abstract][Full Text] [Related]
2. (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1. Dai X; Guo G; Zou P; Cui R; Chen W; Chen X; Yin C; He W; Vinothkumar R; Yang F; Zhang X; Liang G J Exp Clin Cancer Res; 2017 Sep; 36(1):120. PubMed ID: 28882182 [TBL] [Abstract][Full Text] [Related]
3. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal. Ji J; Chen W; Lian W; Chen R; Yang J; Zhang Q; Weng Q; Khan Z; Hu J; Chen X; Zou P; Chen X; Liang G Cell Death Dis; 2018 May; 9(6):660. PubMed ID: 29855474 [TBL] [Abstract][Full Text] [Related]
4. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures. van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572 [TBL] [Abstract][Full Text] [Related]
5. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model. Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797 [TBL] [Abstract][Full Text] [Related]
6. Anticancer effect of crizotinib on osteosarcoma cells by targeting c-Met signaling pathway. Jia T; Cai M; Wang Z; Chen T Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):174-178. PubMed ID: 37571883 [TBL] [Abstract][Full Text] [Related]
7. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Huber KV; Salah E; Radic B; Gridling M; Elkins JM; Stukalov A; Jemth AS; Göktürk C; Sanjiv K; Strömberg K; Pham T; Berglund UW; Colinge J; Bennett KL; Loizou JI; Helleday T; Knapp S; Superti-Furga G Nature; 2014 Apr; 508(7495):222-7. PubMed ID: 24695225 [TBL] [Abstract][Full Text] [Related]
8. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma. Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550 [TBL] [Abstract][Full Text] [Related]
9. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good? Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172 [TBL] [Abstract][Full Text] [Related]
10. MutT Homolog1 has multifaceted role in glioma and is under the apparent orchestration by Hypoxia Inducible factor1 alpha. Bhavya B; Easwer HV; Vilanilam GC; Anand CR; Sreelakshmi K; Urulangodi M; Rajalakshmi P; Neena I; Padmakrishnan CJ; Menon GR; Krishnakumar K; Deepti AN; Gopala S Life Sci; 2021 Jan; 264():118673. PubMed ID: 33130078 [TBL] [Abstract][Full Text] [Related]
11. Potent and specific MTH1 inhibitors targeting gastric cancer. Zhou W; Ma L; Yang J; Qiao H; Li L; Guo Q; Ma J; Zhao L; Wang J; Jiang G; Wan X; Adam Goscinski M; Ding L; Zheng Y; Li W; Liu H; Suo Z; Zhao W Cell Death Dis; 2019 Jun; 10(6):434. PubMed ID: 31164636 [TBL] [Abstract][Full Text] [Related]
12. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways. Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867 [TBL] [Abstract][Full Text] [Related]
13. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
14. Ouabain Induces Apoptotic Cell Death Through Caspase- and Mitochondria-dependent Pathways in Human Osteosarcoma U-2 OS Cells. Chou WH; Liu KL; Shih YL; Chuang YY; Chou J; Lu HF; Jair HW; Lee MZ; Au MK; Chung JG Anticancer Res; 2018 Jan; 38(1):169-178. PubMed ID: 29277770 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells. Lee JW; Lee S; Ho JN; Youn JI; Byun SS; Lee E Biosci Biotechnol Biochem; 2019 Dec; 83(12):2265-2271. PubMed ID: 31362565 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress. Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868 [TBL] [Abstract][Full Text] [Related]
17. Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations. Niu Y; Pan D; Shi D; Bai Q; Liu H; Yao X PLoS One; 2015; 10(12):e0145219. PubMed ID: 26677850 [TBL] [Abstract][Full Text] [Related]
18. Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition. Megiorni F; McDowell HP; Camero S; Mannarino O; Ceccarelli S; Paiano M; Losty PD; Pizer B; Shukla R; Pizzuti A; Clerico A; Dominici C J Exp Clin Cancer Res; 2015 Oct; 34():112. PubMed ID: 26445453 [TBL] [Abstract][Full Text] [Related]
19. Capsaicin inhibits proliferation and induces apoptosis in osteosarcoma cell lines via the mitogen‑activated protein kinase pathway. Zhang Y; Deng X; Lei T; Yu C; Wang Y; Zhao G; Luo X; Tang K; Quan Z; Jiang D Oncol Rep; 2017 Nov; 38(5):2685-2696. PubMed ID: 29048662 [TBL] [Abstract][Full Text] [Related]
20. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia. Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]